Sam Nightingale
Overview
Explore the profile of Sam Nightingale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly S, Nightingale S, Gupta R, Collier D
Trop Med Infect Dis
. 2025 Feb;
10(2).
PMID: 39998049
Neurocognitive impairment is an important cause of HIV-associated morbidity. The advent of antiretroviral therapy (ART) has shifted the spectrum of HIV-associated cognitive impairment from HIV-associated dementia to milder forms of...
2.
Corley M, Letendre S, Nightingale S
Top Antivir Med
. 2025 Jan;
32(4):513-522.
PMID: 39746672
The 2024 Conference on Retroviruses and Opportunistic Infections featured new and impactful findings about neuropsychiatric complications in people with HIV and other infections. Reports included new evidence from low- and...
3.
Dreyer A, Le Roux C, Thomas K, Gf Thomas K, Sabin C, Winston A, et al.
AIDS
. 2024 Dec;
39(4):393-402.
PMID: 39621015
Objective: To investigate whether psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV. Design: Cross-sectional study of 273 participants (178 persons...
4.
Nightingale S, Dreyer A, Thomas K, van Zyl G, Decloedt E, Naude P, et al.
Lancet HIV
. 2024 Sep;
11(10):e680-e689.
PMID: 39284338
Background: Both efavirenz and dolutegravir have been associated with neuropsychiatric side-effects and cognitive impairment. Furthermore, cerebrospinal fluid (CSF) HIV RNA escape has not been comprehensively studied in African populations. We...
5.
Kalaria R, Maestre G, Mahinrad S, Acosta D, Akinyemi R, Alladi S, et al.
Alzheimers Dement
. 2024 May;
20(6):4290-4314.
PMID: 38696263
Two of every three persons living with dementia reside in low- and middle-income countries (LMICs). The projected increase in global dementia rates is expected to affect LMICs disproportionately. However, the...
6.
Nightingale S, Cinque P, Dravid A, Dreyer A, Gisslen M, Joska J, et al.
Nat Rev Neurol
. 2024 Jan;
20(2):129-130.
PMID: 38228907
No abstract available.
7.
Nightingale S, Ssemmanda S, Tucker L, Eastman R, Lee Pan E
PLoS One
. 2023 Nov;
18(11):e0288055.
PMID: 37948398
Introduction: To examine electroencephalogram (EEG) as a diagnostic tool for late-onset efavirenz (EFV) neurotoxicity syndrome (LENS), an uncommon but severe and potentially fatal complication of EFV therapy. Methods: We conducted...
8.
Dreyer A, Nightingale S, Andersen L, Lee J, Gouse H, Safren S, et al.
J Int Assoc Provid AIDS Care
. 2023 Oct;
22:23259582231203192.
PMID: 37787183
Women with HIV (WWH) may be more vulnerable to cognitive impairment than men with HIV (MWH), which may be explained by the direct effects of HIV or by sociodemographic and...
9.
Nightingale S, Ances B, Cinque P, Dravid A, Dreyer A, Gisslen M, et al.
Nat Rev Neurol
. 2023 Jun;
19(7):424-433.
PMID: 37311873
Current approaches to classifying cognitive impairment in people living with HIV can overestimate disease burden and lead to ambiguity around disease mechanisms. The 2007 criteria for HIV-associated neurocognitive disorders (HAND),...
10.
Maestre G, Carrillo M, Kalaria R, Acosta D, Adams L, Adoukonou T, et al.
Alzheimers Dement
. 2023 Mar;
PMID: 36905253
No abstract available.